Abstract:Background: Pulmonary arterial hypertension (PAH) is characterized by abnormal growth and enhanced glycolysis of pulmonary artery endothelial cells. However, the mechanisms underlying alterations in energy production have not been identified. Methods: Here, we examined the miRNA and proteomic profiles of blood outgrowth endothelial cells (BOECs) from patients with heritable PAH caused by mutations in the bone morphogenetic protein receptor type 2 ( BMPR2 ) gene and patients with idiopathic PAH to determine mechanisms underlying abnormal endothelial glycolysis. We hypothesized that in BOECs from patients with PAH, the downregulation of microRNA-124 (miR-124), determined with a tiered systems biology approach, is responsible for increased expression of the splicing factor PTBP1 (polypyrimidine tract binding protein), resulting in alternative splicing of pyruvate kinase muscle isoforms 1 and 2 (PKM1 and 2) and consequently increased PKM2 expression. We questioned whether this alternative regulation plays a critical role in the hyperglycolytic phenotype of PAH endothelial cells. Results: Heritable PAH and idiopathic PAH BOECs recapitulated the metabolic abnormalities observed in pulmonary artery endothelial cells from patients with idiopathic PAH, confirming a switch from oxidative phosphorylation to aerobic glycolysis. Overexpression of miR-124 or siRNA silencing of PTPB1 restored normal proliferation and glycolysis in heritable PAH BOECs, corrected the dysregulation of glycolytic genes and lactate production, and partially restored mitochondrial respiration. BMPR2 knockdown in control BOECs reduced the expression of miR-124, increased PTPB1 , and enhanced glycolysis. Moreover, we observed reduced miR-124, increased PTPB1 and PKM2 expression, and significant dysregulation of glycolytic genes in the rat SUGEN-hypoxia model of severe PAH, characterized by reduced BMPR2 expression and endothelial hyperproliferation, supporting the relevance of this mechanism in vivo. Conclusions: Pulmonary vascular and circulating progenitor endothelial cells isolated from patients with PAH demonstrate downregulation of miR-124, leading to the metabolic and proliferative abnormalities in PAH ECs via PTPB1 and PKM1/PKM2. Therefore, the manipulation of this miRNA or its targets could represent a novel therapeutic approach for the treatment of PAH.

Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline.

MicroRNA-mRNA interactions in a murine model of hyperoxia-induced bronchopulmonary dysplasia

Long Noncoding RNA Expression Profiles of Hypoxic Pulmonary Hypertension Rat Model.

Differential Expression of Microrna in the Lungs of Rats with Pulmonary Arterial Hypertension

Mir-145: A Role in the Development of Pulmonary Arterial Hypertension

MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells

Upregulation of MicroRNA-214 Contributes to the Development of Vascular Remodeling in Hypoxia-induced Pulmonary Hypertension Via Targeting CCNL2

MicroRNA-210 mediates hypoxia-induced pulmonary hypertension by targeting mitochondrial bioenergetics and mtROS flux

Pulmonary microRNA profiling: implications in upper lobe predominant lung disease

MiR-126a-5p is Involved in the Hypoxia-Induced Endothelial-to-mesenchymal Transition of Neonatal Pulmonary Hypertension.

Dysregulation Of Microrna-214 And Pten Contributes To The Pathogenesis Of Hypoxic Pulmonary Hypertension

miR-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension

MicroRNA Expression Profile in Intrauterine Hypoxia-Induced Pulmonary Hypoplasia in Rats

Identification of microRNAs changed in the neonatal lungs in response to hyperoxia exposure.

Human lung microRNA profiling in pulmonary arterial hypertension secondary to congenital heart defect.

MicroRNA‐483 Amelioration of Experimental Pulmonary Hypertension

Identification of MicroRNA-124 As a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension Via PTBP1 (polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2

151 Microrna Regulation of Phenotypically Transformed Normal Pulmonary Artery Endothelial Cells

MicroRNA-663 Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension by Targeting TGF-β1/smad2/3 Signaling

Profiling and Molecular Mechanism Analysis of Long Non-Coding RNAs and mRNAs in Pulmonary Arterial Hypertension Rat Models

MicroRNA‐140‐5p Targeting Tumor Necrosis Factor‐α Prevents Pulmonary Arterial Hypertension